Disclosed are methods of treating taxane sensitive tumors (i.e., cancers treatable with taxanes) using a taxane and the discontinuous dosing of lonafarnib.

 
Web www.patentalert.com

< Anti-human DLL4 antibodies and compositions

< Antibodies that bind to a member of the IL-6/G-CSF/MGF family

> COMPOSITION AND METHODS FOR MODULATING CELL PROLIFERATION AND CELL DEATH

> Enteric coatings for orally ingestible substrates
~ 00601